S551-0609 Screening compound: N-{[7-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide

S551-0609 Screening compound: N-{[7-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide
S551-0609 Screening compound: N-{[7-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S551-0609
N-{[7-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S551-0609

Molecular Formula

C21H21N7O2 (C21 H21 N7 O2)

Compound Name

N-{[7-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide

IUPAC name

N-{[7-(3-cyclopropyl-124-oxadiazol-5-yl)-[124]triazolo[43-a]pyridin-3-yl]methyl}-4-(dimethylamino)benzamide

SMILES

CN(C)c(cc1)ccc1C(NCc1nnc2n1ccc(-c1nc(C3CC3)no1)c2)=O

InChI

InChI=1S/C21H21N7O2/c1-27(2)16-7-5-14(6-8-16)20(29)22-12-18-25-24-17-11-15(9-10-28(17)18)21-23-19(26-30-21)13-3-4-13/h5-11,13H,3-4,12H2,1-2H3,(H,22,29)

InChI Key

REQWXRUMBAYFTH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29009464

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

403.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.383

Distribution Coefficient, logD

2.383

Water Solubility, LogSw

-2.85

Polar Surface Area

81.972

Acid Dissociation Constant (pKa)

11.23

Base Dissociation Constant (pKb)

8.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

S551-0609 in Drug Discovery

Included in Screening Libraries

Antifungal Library (16415 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Agro:
  • Agro
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with S551-0609 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S551-0609?
Check Price and Availability of S551-0609, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S551-0609 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S551-0609
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S551-0609
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S551-0609 available by request